CELLUMED CO., LTD.

049180 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ

Shareholding pattern

As reported to FSS/DART, 2025-12-31.

Largest shareholder group23.49%
Minority shareholders75.02%
Top 10 holders23.50%
Total shareholders29,462

Who owns the company

Share of shares outstanding
Minority shareholders: 75.02%Largest shareholder & related parties: 23.49%Institutions & other holders: 1.49%75%Minority shareholders
Minority shareholders 75.02%Largest shareholder & related parties 23.49%Institutions & other holders 1.49%

How to read this: the largest shareholder group is the controlling owner and related parties — a big slice means tight control. Minority shareholders are the many small holders. The remainder is mostly institutional and foreign money, which the regulator does not itemise separately.

Ownership detail

Investor categoryHolding %Shareholders
Minority shareholders75.02%29,459
Largest shareholder & related parties23.49%
Institutions & other holders1.49%

How to read this: a high foreign or institutional share often means the stock is widely researched and more liquid; a high individual share means retail investors hold most of the company. Percentages are of voting units.

Largest shareholders

S.No.ShareholderSharesStake %
1(주)인스코비10,060,36618.31%
2(주)프리텔레콤2,571,4284.68%
3구자갑130,0730.24%
4김용회76,9230.14%
5박민자60,0000.11%
6유인수10,0000.02%

Trust banks such as Master Trust and Custody Bank appear at the top of most Japanese registers: they hold shares on behalf of many underlying funds rather than owning them outright.

Educational data only. Not a recommendation to buy, sell or hold any security.